Announcements Trials
Browse Landscape

Phase

Phase 2 6Phase 3 5Phase 1 5Phase 1/2 2Phase 2/3 1

Status

Completed 5Terminated 1

Sponsor Class

NIH 3OTHER 1NETWORK 1INDUSTRY 1

Study Type

Interventional 6

Sponsor

Cancer Type

Gynecologic 2Thoracic 1Sarcoma 1Head & Neck 1Gastrointestinal 1

Conditions

Uterine Cervical Neoplasms 1Recurrence 1Ovarian Neoplasms 1Limited Stage Small Cell Lung Cancer 1Head and Neck Neoplasms 1Carcinoma, Ovarian Epithelial 1Carcinoma, Hepatocellular 1Alveolar Childhood Rhabdomyosarcoma 1

Interventions

Cisplatin 1519Carboplatin 1420Cyclophosphamide 1360Gemcitabine 1235Bevacizumab 1226Paclitaxel 1211Radiotherapy 1176Docetaxel 1080pembrolizumab 1028Oxaliplatin 936Capecitabine 900Fluorouracil 833Rituximab 729Doxorubicin 683Nivolumab 679Dexamethasone 666Etoposide 660Irinotecan 622Leucovorin 575Pemetrexed 510Drug Therapy 493Cetuximab 483Trastuzumab 469Cytarabine 466Magnetic Resonance Spectroscopy 458Filgrastim 446Prednisone 432Lenalidomide 409Specimen Handling 408Temozolomide 400

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase 2 × Interventional × Tirapazamine × Clear all
NCT03145558 2024-11-22

TATE

Teclison Ltd.

Phase 2 Terminated
6 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT00002774 2014-06-20

Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer

Stanford University

Phase 2 Completed
63 enrolled
Head & Neck

Head and Neck Neoplasms, Recurrence

NCT00066742 2014-05-15

Tirapazamine Combined With Chemo and RT in Limited-Stage Small Cell Lung Cancer

National Cancer Institute (NCI)

Phase 2 Completed
72 enrolled 8 charts
Thoracic

Limited Stage Small Cell Lung Cancer

NCT00025363 2013-01-17

Comparison of Chemotherapy Regimens in Treating Children With Relapsed or Progressive Rhabdomyosarcoma

National Cancer Institute (NCI)

Phase 2 Completed
150 enrolled
Sarcoma

Alveolar Childhood Rhabdomyosarcoma

NCT00003369 2012-06-14

S9717 Tirapazamine Plus Cisplatin in Treating Patients With Metastatic, Recurrent, or Refractory Cervical Cancer

SWOG Cancer Research Network

Phase 2 Completed
56 enrolled
Gynecologic

Uterine Cervical Neoplasms

NCT00020696 2012-01-10

Tirapazamine Plus Cisplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial or Primary Peritoneal Cancer

National Cancer Institute (NCI)

Phase 2 Completed
Gynecologic

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡